Vicapsys Life Sciences, Inc. (VICP)
1.45
0.00 (0.00%)
USD |
OTCM |
Aug 21, 16:00
Vicapsys Life Sciences Shareholders Equity (Quarterly) : -3.549M for March 31, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2026 | -3.549M |
| March 31, 2025 | -3.064M |
| December 31, 2024 | -2.883M |
| September 30, 2024 | -2.646M |
| June 30, 2024 | -2.446M |
| March 31, 2024 | -2.256M |
| December 31, 2023 | -1.929M |
| September 30, 2023 | -1.334M |
| June 30, 2023 | -1.094M |
| March 31, 2023 | -1.141M |
| December 31, 2022 | -0.9508M |
| September 30, 2022 | -0.5203M |
| June 30, 2022 | -0.4666M |
| March 31, 2022 | -0.2876M |
| December 31, 2021 | -0.1217M |
| September 30, 2021 | -0.1939M |
| June 30, 2021 | -0.2588M |
| March 31, 2021 | -0.3978M |
| December 31, 2020 | -0.4491M |
| September 30, 2020 | -0.3696M |
| June 30, 2020 | -0.2833M |
| March 31, 2020 | -0.0571M |
| December 31, 2019 | 0.302M |
| September 30, 2019 | |
| June 30, 2019 |
| Date | Value |
|---|---|
| March 31, 2019 | |
| December 31, 2018 | -0.2537M |
| September 30, 2018 | |
| June 30, 2018 | |
| March 31, 2018 | |
| December 31, 2017 | |
| September 30, 2017 | |
| June 30, 2017 | |
| March 31, 2017 | |
| December 31, 2016 | |
| September 30, 2016 | |
| June 30, 2016 | |
| March 31, 2016 | |
| December 31, 2015 | |
| September 30, 2015 | |
| June 30, 2015 | |
| March 31, 2015 | |
| December 31, 2014 | |
| September 30, 2014 | |
| June 30, 2014 | |
| March 31, 2014 | |
| December 31, 2013 | |
| September 30, 2013 | |
| June 30, 2013 | |
| March 31, 2013 |
Shareholders' Equity Definition
Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Arrowhead Pharmaceuticals, Inc. | 465.53M |
| Oncolytics Biotech, Inc. | -6.167M |
| Sangamo Therapeutics, Inc. | -18.96M |
| Sarepta Therapeutics, Inc. | 1.528B |
| Anixa Biosciences, Inc. | 14.48M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 0.1325M |
| Total Liabilities (Quarterly) | 3.682M |
| Debt to Equity Ratio | -0.1759 |
| Current Ratio | 0.036 |
| Net Debt Paydown Yield | -0.07% |